Thermo Fisher (TMO) Stock Forecast & Price Target

Compare

4,685 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

TMO Analyst Ratings

Strong Buy

17 Buy

2 Hold

0 Sell

Based on 19 analysts giving stock ratings to

Thermo

Fisher

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

TMO Stock 12 Month Forecast

Average Price Target

$562.56

▲(41.22%Upside)

Based on 19 Wall Street analysts offering 12 month price targets for Thermo Fisher in the last 3 months. The average price target is $562.56 with a high forecast of $637.00 and a low forecast of $475.00. The average price target represents a 41.22% change from the last price of $398.36.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"395":"$395","638":"$638","455.75":"$455.8","516.5":"$516.5","577.25":"$577.3"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":637,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">$637.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":562.56,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">$562.56</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":475,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">$475.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[395,455.75,516.5,577.25,638],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Sep<br/>2024","6":"Dec<br/>2024","9":"Mar<br/>2025","12":"Jun<br/>2025","25":"Jun<br/>2026"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,396.47,414.9723076923077,433.4746153846154,451.9769230769231,470.47923076923075,488.98153846153843,507.4838461538462,525.9861538461539,544.4884615384615,562.9907692307693,581.4930769230768,599.9953846153846,618.4976923076923,{"y":637,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,396.47,409.24615384615385,422.0223076923077,434.79846153846154,447.5746153846154,460.35076923076923,473.12692307692305,485.9030769230769,498.67923076923074,511.45538461538456,524.2315384615384,537.0076923076922,549.7838461538461,{"y":562.56,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,396.47,402.51076923076926,408.5515384615385,414.5923076923077,420.63307692307694,426.67384615384617,432.7146153846154,438.7553846153846,444.79615384615386,450.8369230769231,456.8776923076923,462.91846153846154,468.95923076923077,{"y":475,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":566.33,"date":1717200000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":540.52,"date":1719792000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":620.39,"date":1722470400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":613.7,"date":1725148800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":611.97,"date":1727740800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":557.03,"date":1730419200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 31,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":529.11,"date":1733011200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":519.79,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 23,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":597.24,"date":1738368000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 30,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":528.51,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":482.97,"date":1743465600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 34,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":419.89,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 27,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":396.47,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 28,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 3, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price Target$637.00

Average Price Target$562.56

Lowest Price Target$475.00

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Michael RyskinBank of America Securities

Bank of America Securities

$545

Buy

36.81%

Upside

Reiterated

06/03/25

Bank of America Securities Sticks to Its Buy Rating for Thermo Fisher (TMO)

David ToungArgus Research

Argus Research

―

Buy

―

Reiterated

04/28/25

Analysts Are Bullish on Top Healthcare Stocks: NeoGenomics (NEO), Thermo Fisher (TMO)

Jill WuCMB International Securities

CMB International Securities

$690→$526

Buy

32.04%

Upside

Reiterated

04/25/25

Thermo Fisher's Strategic Resilience Amid Macroeconomic Challenges: A Buy Recommendation

Sung Ji NamScotiabank

Scotiabank

$650→$605

Hold

51.87%

Upside

Reiterated

04/25/25

Scotiabank Sticks to Their Hold Rating for Thermo Fisher (TMO)

Brandon CouillardWells Fargo

Wells Fargo

$580→$570

Buy

43.09%

Upside

Reiterated

04/24/25

Thermo Fisher Scientific (TMO) PT Lowered to $570 at Wells FargoWells Fargo analyst Brandon Couillard lowered the price target on Thermo Fisher Scientific (NYSE: TMO) to $570.00 (from $580.00) while maintaining a Overweight rating.

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$603→$573

Buy

43.84%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $573 from $603 at BairdThermo Fisher price target lowered to $573 from $603 at Baird

Eve BursteinBernstein

Bernstein

$585→$560

Buy

40.58%

Upside

Reiterated

04/24/25

Thermo Fisher Scientific (TMO) PT Lowered to $560 at Bernstein SocGen GroupBernstein SocGen Group analyst Eve Burstein lowered the price target on Thermo Fisher Scientific (NYSE: TMO) to $560.00 (from $585.00) while maintaining a Outperform rating.

Tejas SavantMorgan Stanley

Morgan Stanley

$678→$550

Buy

38.07%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Edwards Lifesciences (NYSE: EW) and Viking Therapeutics (NASDAQ: VKTX)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$665→$620

Buy

55.64%

Upside

Reiterated

04/24/25

Stifel Nicolaus Remains a Buy on Thermo Fisher (TMO)

Andrew CooperRaymond James

Raymond James

$667→$525

Buy

31.79%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $525 from $667 at Raymond JamesThermo Fisher price target lowered to $525 from $667 at Raymond James

Luke SergottBarclays

Barclays

$475

Hold

19.24%

Upside

Reiterated

04/24/25

Barclays Sticks to Their Hold Rating for Thermo Fisher (TMO)

John SourbeerUBS

UBS

$715→$500

Buy

25.51%

Upside

Reiterated

04/24/25

Thermo Fisher Scientific (TMO) PT Lowered to $500 at UBSUBS analyst John Sourbeer lowered the price target on Thermo Fisher Scientific (NYSE: TMO) to $500.00 (from $715.00) while maintaining a Buy rating.

Puneet SoudaLeerink Partners

Leerink Partners

$625→$600

Buy

50.62%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $600 from $625 at LeerinkThermo Fisher price target lowered to $600 from $625 at Leerink

Daniel BrennanTD Cowen

TD Cowen

$600→$570

Buy

43.09%

Upside

Reiterated

04/23/25

Positive Outlook for Thermo Fisher Amid Tariff Challenges and Cost Mitigation Strategies

Tycho PetersonJefferies

Jefferies

$655→$560

Buy

40.58%

Upside

Reiterated

04/23/25

Thermo Fisher's Strategic Resilience Amidst Economic Challenges: A Buy Recommendation

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Michael RyskinBank of America Securities

Bank of America Securities

$545

Buy

36.81%

Upside

Reiterated

06/03/25

Bank of America Securities Sticks to Its Buy Rating for Thermo Fisher (TMO)

David ToungArgus Research

Argus Research

―

Buy

―

Reiterated

04/28/25

Analysts Are Bullish on Top Healthcare Stocks: NeoGenomics (NEO), Thermo Fisher (TMO)

Jill WuCMB International Securities

CMB International Securities

$690→$526

Buy

32.04%

Upside

Reiterated

04/25/25

Thermo Fisher's Strategic Resilience Amid Macroeconomic Challenges: A Buy Recommendation

Sung Ji NamScotiabank

Scotiabank

$650→$605

Hold

51.87%

Upside

Reiterated

04/25/25

Scotiabank Sticks to Their Hold Rating for Thermo Fisher (TMO)

Brandon CouillardWells Fargo

Wells Fargo

$580→$570

Buy

43.09%

Upside

Reiterated

04/24/25

Catherine Ramsey SchulteRobert W. Baird

Robert W. Baird

$603→$573

Buy

43.84%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $573 from $603 at BairdThermo Fisher price target lowered to $573 from $603 at Baird

Eve BursteinBernstein

Bernstein

$585→$560

Buy

40.58%

Upside

Reiterated

04/24/25

Tejas SavantMorgan Stanley

Morgan Stanley

$678→$550

Buy

38.07%

Upside

Reiterated

04/24/25

Analysts Offer Insights on Healthcare Companies: Thermo Fisher (NYSE: TMO), Edwards Lifesciences (NYSE: EW) and Viking Therapeutics (NASDAQ: VKTX)

Daniel AriasStifel Nicolaus

Stifel Nicolaus

$665→$620

Buy

55.64%

Upside

Reiterated

04/24/25

Stifel Nicolaus Remains a Buy on Thermo Fisher (TMO)

Andrew CooperRaymond James

Raymond James

$667→$525

Buy

31.79%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $525 from $667 at Raymond JamesThermo Fisher price target lowered to $525 from $667 at Raymond James

Luke SergottBarclays

Barclays

$475

Hold

19.24%

Upside

Reiterated

04/24/25

Barclays Sticks to Their Hold Rating for Thermo Fisher (TMO)

John SourbeerUBS

UBS

$715→$500

Buy

25.51%

Upside

Reiterated

04/24/25

Puneet SoudaLeerink Partners

Leerink Partners

$625→$600

Buy

50.62%

Upside

Reiterated

04/24/25

Thermo Fisher price target lowered to $600 from $625 at LeerinkThermo Fisher price target lowered to $600 from $625 at Leerink

Daniel BrennanTD Cowen

TD Cowen

$600→$570

Buy

43.09%

Upside

Reiterated

04/23/25

Positive Outlook for Thermo Fisher Amid Tariff Challenges and Cost Mitigation Strategies

Tycho PetersonJefferies

Jefferies

$655→$560

Buy

40.58%

Upside

Reiterated

04/23/25

Thermo Fisher's Strategic Resilience Amidst Economic Challenges: A Buy Recommendation

Stocks with the Highest Top Analyst Consensus in the Healthcare Sector

xxx

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Thermo Fisher

1 Month

xxx

Success Rate

11/20 ratings generated profit

Average Return

+0.07%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 1 Month would result in 55.00% of your transactions generating a profit, with an average return of +0.07% per trade.

3 Months

xxx

Success Rate

29/42 ratings generated profit

Average Return

+3.65%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 69.05% of your transactions generating a profit, with an average return of +3.65% per trade.

1 Year

Catherine Ramsey SchulteRobert W. Baird

Success Rate

26/42 ratings generated profit

Average Return

+10.96%

reiterated a buy rating last month

Copying Catherine Ramsey Schulte's trades and holding each position for 1 Year would result in 61.90% of your transactions generating a profit, with an average return of +10.96% per trade.

2 Years

xxx

Success Rate

26/42 ratings generated profit

Average Return

+20.72%

reiterated a xxx

rating last month

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 61.90% of your transactions generating a profit, with an average return of +20.72% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

TMO Analyst Recommendation Trends

Rating

Feb 25

Mar 25

Apr 25

May 25

Jun 25

Strong Buy

Buy

Hold

Sell

Strong Sell

total

In the current month, TMO has received 28 Buy Ratings, 3 Hold Ratings, and 0 Sell Ratings. TMO average Analyst price target in the past 3 months is 562.56.

Each month's total comprises the sum of three months' worth of ratings.

TMO Financial Forecast

TMO Earnings Forecast

Next quarter’s earnings estimate for TMO is $5.23 with a range of $5.19 to $5.43. The previous quarter’s EPS was $5.15. TMO beat its EPS estimate 100.00% of the time in the past 12 months, while its overall industry beat the EPS estimate 58.04% of the time in the same period. In the last calendar year TMO has Outperformed its overall industry.

TMO Sales Forecast

Next quarter’s sales forecast for TMO is $10.68B with a range of $10.49B to $10.75B. The previous quarter’s sales results were $10.36B. TMO beat its sales estimates 75.00% of the time in past 12 months, while its overall industry beat sales estimates 47.51% of the time in the same period. In the last calendar year TMO has Outperformed its overall industry.

TMO Stock Forecast FAQ

What is TMO’s average 12-month price target, according to analysts?

Based on analyst ratings, Thermo Fisher’s 12-month average price target is 562.56.

What is TMO’s upside potential, based on the analysts’ average price target?

Thermo Fisher has 41.22% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TMO a Buy, Sell or Hold?

Thermo Fisher has a consensus rating of Strong Buy which is based on 17 buy ratings, 2 hold ratings and 0 sell ratings.

What is Thermo Fisher’s price target?

The average price target for Thermo Fisher is 562.56. This is based on 19 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is $637.00 ,the lowest forecast is $475.00. The average price target represents 41.22% Increase from the current price of $398.36.

What do analysts say about Thermo Fisher?

Thermo Fisher’s analyst rating consensus is a Strong Buy. This is based on the ratings of 19 Wall Streets Analysts.

How can I buy shares of TMO?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing

Thermo Fisher (TMO) Stock Forecast & Price Target

TMO Analyst Ratings

TMO Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Thermo Fisher

TMO Analyst Recommendation Trends

TMO Financial Forecast

TMO Earnings Forecast

TMO Sales Forecast

TMO Stock Forecast FAQ

Become an Expert with TipRanks Premium

Detailed List of Analyst Forecasts